{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:19:32Z","timestamp":1766391572640,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR190104"],"award-info":[{"award-number":["RR190104"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AIM-AHEAD 3OT2OD032581"],"award-info":[{"award-number":["AIM-AHEAD 3OT2OD032581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL159271"],"award-info":[{"award-number":["K23 HL159271"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.thromres.2023.03.001","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T13:05:25Z","timestamp":1678885525000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA)"],"prefix":"10.1016","volume":"225","author":[{"given":"Zhihui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spiridon","family":"Tsavachidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher I.","family":"Amos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Sartain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Afshar-Kharghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan","family":"Bhatraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Makar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan K.","family":"Bendapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2023.03.001_bb0005","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond : hematopoietic stem cell transplantation \u2013 associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2023.03.001_bb0010","article-title":"Incidence and risk factors of transplantation-associated thrombotic microangiopathy: a systematic review and meta-analysis","volume":"28","author":"Van Benschoten","year":"2022","journal-title":"Transplant Cell Ther."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.001_bb0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.001_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","article-title":"Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal","volume":"25","author":"Li","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.thromres.2023.03.001_bb0025","article-title":"Prognostic biomarkers for thrombotic microangiopathy after acute graft-versus-host disease: a nested case-control study","volume":"27","author":"Li","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"5","key":"10.1016\/j.thromres.2023.03.001_bb0030","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bjh.13658","article-title":"Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA research collaborative","volume":"171","author":"Bendapudi","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.03.001_bb0035","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","article-title":"Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation","volume":"24","author":"Horv\u00e1th","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.thromres.2023.03.001_bb0040","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28070","article-title":"The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy","volume":"67","author":"Sartain","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"July","key":"10.1016\/j.thromres.2023.03.001_bb0050","article-title":"Early elevation of complement factor Ba is a predictive biomarker for transplant-associated thrombotic microangiopathy","volume":"12","author":"Okamura","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2023.03.001_bb0055","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.bbmt.2018.12.122","article-title":"Thrombotic microangiopathy after pediatric allogeneic stem cell transplant: potential early markers to predict individuals at high-risk","volume":"25","author":"Dandoy","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.thromres.2023.03.001_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<213::AID-AJH1>3.0.CO;2-0","article-title":"Plasma von willebrand factor antigen (vWF : AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura\/hemolytic uremic syndromes (TTP \/ HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM)","volume":"220","author":"Zeigler","year":"1996","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.03.001_bb0070","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.thj.6200127","article-title":"Von willebrand factor-cleaving protease activity and proteolysis of von willebrand factor in bone marrow transplant-associated thrombotic microangiopathy","volume":"2","author":"Arai","year":"2001","journal-title":"Hematol. J."},{"issue":"8","key":"10.1016\/j.thromres.2023.03.001_bb0075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2023.03.001_bb0080","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0040-1702225","article-title":"Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy","volume":"120","author":"Gavriilaki","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2023.03.001_bb0085","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41576-019-0177-4","article-title":"Rare-variant collapsing analyses for complex traits: guidelines and applications","volume":"20","author":"Povysil","year":"2019","journal-title":"Nat Rev Genet."},{"issue":"10","key":"10.1016\/j.thromres.2023.03.001_bb0095","doi-asserted-by":"crossref","first-page":"864.e1","DOI":"10.1016\/j.jtct.2021.06.027","article-title":"Thrombotic microangiopathy increases the risk of chronic kidney disease but not overall mortality in long-term transplant survivors","volume":"27","author":"Li","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.001_bb0100","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"D1","key":"10.1016\/j.thromres.2023.03.001_bb0105","doi-asserted-by":"crossref","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation","volume":"44","author":"O\u2019Leary","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.thromres.2023.03.001_bb0110","article-title":"Using VarScan 2 for germline variant calling and somatic mutation detection","volume":"44(1):15.4.1-17","author":"Koboldt","year":"2013","journal-title":"Curr. Protoc. Bioinformatics"},{"year":"2009","series-title":"BLAST+: Architecture and Applications","author":"Camacho","key":"10.1016\/j.thromres.2023.03.001_bb0115"},{"issue":"22","key":"10.1016\/j.thromres.2023.03.001_bb0120","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","article-title":"Robust relationship inference in genome-wide association studies","volume":"26","author":"Manichaikul","year":"2010","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.thromres.2023.03.001_bb0125","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.thromres.2023.03.001_bb0130","doi-asserted-by":"crossref","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","article-title":"Ensembl 2021","volume":"49","author":"Howe","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"7809","key":"10.1016\/j.thromres.2023.03.001_bb0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2023.03.001_bb0140","article-title":"The ExAC browser: displaying reference data information from over 60 000 exomes","volume":"45(Database issue):D840","author":"Karczewski","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"7571","key":"10.1016\/j.thromres.2023.03.001_bb0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.thromres.2023.03.001_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensemble variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"issue":"D1","key":"10.1016\/j.thromres.2023.03.001_bb0155","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.thromres.2023.03.001_bb0160","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J. Immunol."},{"year":"2022","series-title":"Evidence-based Calibration of Computational Tools for Missense Variant Pathogenicity Classification and ClinGen Recommendations for Clinical Use of PP3\/BP4 Criteria","author":"Pejaver","key":"10.1016\/j.thromres.2023.03.001_bb0165"},{"issue":"1","key":"10.1016\/j.thromres.2023.03.001_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajhg.2011.05.029","article-title":"Rare-variant association testing for sequencing data with the sequence kernel association test","volume":"89","author":"Wu","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.001_bb0185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.mayocp.2016.05.015","article-title":"Thrombotic microangiopathy care pathway: a consensus statement for the mayo clinic complement alternative pathway-thrombotic microangiopathy (CAP-TMA) disease-oriented group","volume":"91","author":"Go","year":"2016","journal-title":"Mayo Clin. Proc."},{"year":"2020","series-title":"Complement Activity and Complement Regulatory Gene Mutations Are Associated With Thrombosis in APS and CAPS","author":"Chaturvedi","key":"10.1016\/j.thromres.2023.03.001_bb0190"},{"issue":"1","key":"10.1016\/j.thromres.2023.03.001_bb0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an international working group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.thromres.2023.03.001_bb0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.thromres.2023.03.001_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2023.03.001_bb0210","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.thromres.2023.03.001_bb0215","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/bjh.16457","article-title":"Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy","volume":"189","author":"Epperla","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.thromres.2023.03.001_bb0220","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bbmt.2006.06.002","article-title":"Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes","volume":"12","author":"Majhail","year":"2006","journal-title":"Biol Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.thromres.2023.03.001_bb0225","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbmt.2019.09.034","article-title":"Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation","volume":"26","author":"Wenger","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.001_bb0230","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","article-title":"Macrophage LRP1 contributes to the clearance of von Willebrand factor","volume":"119","author":"Rastegarlari","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2023.03.001_bb0235","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2014-09-599530","article-title":"High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion","volume":"127","author":"Chung","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2023.03.001_bb0240","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1182\/blood-2007-12-127613","article-title":"Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor","volume":"111","author":"Gaultier","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.03.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8729398","article-title":"Activation of LRP1 ameliorates cerebral ischemia\/reperfusion injury and cognitive decline by suppressing neuroinflammation and oxidative stress through TXNIP\/NLRP3 signaling pathway in mice","author":"Yang","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.thromres.2023.03.001_bb0250","article-title":"Upregulation of Nrf2 attenuates oxidative stress\u2013induced, complement activation\u2013associated endothelial injury and apoptosis in transplant-associated thrombotic microangiopathy","volume":"27","author":"Zhang","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"8","key":"10.1016\/j.thromres.2023.03.001_bb0255","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.bbmt.2019.03.002","article-title":"Circulating heme oxygenase-1 and complement activation in transplant-associated thrombotic microangiopathy","volume":"25","author":"Pan","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.thromres.2023.03.001_bb0260","article-title":"N-Acetylcysteine as prophylactic therapy for transplantation-associated thrombotic microangiopathy: a randomized, placebo-controlled trial","volume":"28","author":"Pan","year":"2022","journal-title":"Transplant Cell Ther."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482300066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:54Z","timestamp":1758736194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482300066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":48,"alternative-id":["S004938482300066X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA)","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}